Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Growth 2022-2028

  • LP 4793516
  • 109 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Contrast Agents for Magnetic Resonance Imaging (MRI) will have significant change from previous year. According to our (LP Information) latest study, the global Contrast Agents for Magnetic Resonance Imaging (MRI) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Contrast Agents for Magnetic Resonance Imaging (MRI) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Contrast Agents for Magnetic Resonance Imaging (MRI) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Contrast Agents for Magnetic Resonance Imaging (MRI) market, reaching US$ million by the year 2028. As for the Europe Contrast Agents for Magnetic Resonance Imaging (MRI) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Contrast Agents for Magnetic Resonance Imaging (MRI) players cover GE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), and Guerbet (France), etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Contrast Agents for Magnetic Resonance Imaging (MRI) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Barium-based Contrast Media

Iodinated Contrast Media

Gadolinium-based Contrast Media

Microbubble Contrast Media

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Radiology

Interventional Radiology

Interventional Cardiology

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

GE Healthcare (US)

Bracco Imaging (Italy)

Bayer HealthCare (Germany)

Guerbet (France)

Lantheus (US)

Daiichi Sankyo (Japan)

Unijules Life Sciences (India)

J.B. Chemicals and Pharmaceuticals (India)

Spago Nanomedicine (Sweden)

Taejoon Pharm (South Korea)

Jodas (India)

Magnus Health (India)

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Contrast Agents for Magnetic Resonance Imaging (MRI) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Contrast Agents for Magnetic Resonance Imaging (MRI) by Country/Region, 2017, 2022 & 2028

2.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Type

2.2.1 Barium-based Contrast Media

2.2.2 Iodinated Contrast Media

2.2.3 Gadolinium-based Contrast Media

2.2.4 Microbubble Contrast Media

2.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type

2.3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2017-2022)

2.3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sale Price by Type (2017-2022)

2.4 Contrast Agents for Magnetic Resonance Imaging (MRI) Segment by Application

2.4.1 Radiology

2.4.2 Interventional Radiology

2.4.3 Interventional Cardiology

2.5 Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application

2.5.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sale Market Share by Application (2017-2022)

2.5.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sale Price by Application (2017-2022)

3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) by Company

3.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Breakdown Data by Company

3.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Sales by Company (2020-2022)

3.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Company (2020-2022)

3.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Revenue by Company (2020-2022)

3.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Company (2020-2022)

3.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Company (2020-2022)

3.3 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sale Price by Company

3.4 Key Manufacturers Contrast Agents for Magnetic Resonance Imaging (MRI) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Contrast Agents for Magnetic Resonance Imaging (MRI) Product Location Distribution

3.4.2 Players Contrast Agents for Magnetic Resonance Imaging (MRI) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Contrast Agents for Magnetic Resonance Imaging (MRI) by Geographic Region

4.1 World Historic Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Geographic Region (2017-2022)

4.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Revenue by Geographic Region

4.2 World Historic Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size by Country/Region (2017-2022)

4.2.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Revenue by Country/Region

4.3 Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth

4.4 APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth

4.5 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth

4.6 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth

5 Americas

5.1 Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country

5.1.1 Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2017-2022)

5.1.2 Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2017-2022)

5.2 Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type

5.3 Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region

6.1.1 APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2017-2022)

6.1.2 APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2017-2022)

6.2 APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type

6.3 APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) by Country

7.1.1 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2017-2022)

7.1.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2017-2022)

7.2 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type

7.3 Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) by Country

8.1.1 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2017-2022)

8.2 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type

8.3 Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Contrast Agents for Magnetic Resonance Imaging (MRI)

10.3 Manufacturing Process Analysis of Contrast Agents for Magnetic Resonance Imaging (MRI)

10.4 Industry Chain Structure of Contrast Agents for Magnetic Resonance Imaging (MRI)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors

11.3 Contrast Agents for Magnetic Resonance Imaging (MRI) Customer

12 World Forecast Review for Contrast Agents for Magnetic Resonance Imaging (MRI) by Geographic Region

12.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market Size Forecast by Region

12.1.1 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Forecast by Region (2023-2028)

12.1.2 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Forecast by Type

12.7 Global Contrast Agents for Magnetic Resonance Imaging (MRI) Forecast by Application

13 Key Players Analysis

13.1 GE Healthcare (US)

13.1.1 GE Healthcare (US) Company Information

13.1.2 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

13.1.3 GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GE Healthcare (US) Main Business Overview

13.1.5 GE Healthcare (US) Latest Developments

13.2 Bracco Imaging (Italy)

13.2.1 Bracco Imaging (Italy) Company Information

13.2.2 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

13.2.3 Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bracco Imaging (Italy) Main Business Overview

13.2.5 Bracco Imaging (Italy) Latest Developments

13.3 Bayer HealthCare (Germany)

13.3.1 Bayer HealthCare (Germany) Company Information

13.3.2 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

13.3.3 Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bayer HealthCare (Germany) Main Business Overview

13.3.5 Bayer HealthCare (Germany) Latest Developments

13.4 Guerbet (France)

13.4.1 Guerbet (France) Company Information

13.4.2 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

13.4.3 Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Guerbet (France) Main Business Overview

13.4.5 Guerbet (France) Latest Developments

13.5 Lantheus (US)

13.5.1 Lantheus (US) Company Information

13.5.2 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

13.5.3 Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Lantheus (US) Main Business Overview

13.5.5 Lantheus (US) Latest Developments

13.6 Daiichi Sankyo (Japan)

13.6.1 Daiichi Sankyo (Japan) Company Information

13.6.2 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

13.6.3 Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Daiichi Sankyo (Japan) Main Business Overview

13.6.5 Daiichi Sankyo (Japan) Latest Developments

13.7 Unijules Life Sciences (India)

13.7.1 Unijules Life Sciences (India) Company Information

13.7.2 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

13.7.3 Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Unijules Life Sciences (India) Main Business Overview

13.7.5 Unijules Life Sciences (India) Latest Developments

13.8 J.B. Chemicals and Pharmaceuticals (India)

13.8.1 J.B. Chemicals and Pharmaceuticals (India) Company Information

13.8.2 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

13.8.3 J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 J.B. Chemicals and Pharmaceuticals (India) Main Business Overview

13.8.5 J.B. Chemicals and Pharmaceuticals (India) Latest Developments

13.9 Spago Nanomedicine (Sweden)

13.9.1 Spago Nanomedicine (Sweden) Company Information

13.9.2 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

13.9.3 Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Spago Nanomedicine (Sweden) Main Business Overview

13.9.5 Spago Nanomedicine (Sweden) Latest Developments

13.10 Taejoon Pharm (South Korea)

13.10.1 Taejoon Pharm (South Korea) Company Information

13.10.2 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

13.10.3 Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Taejoon Pharm (South Korea) Main Business Overview

13.10.5 Taejoon Pharm (South Korea) Latest Developments

13.11 Jodas (India)

13.11.1 Jodas (India) Company Information

13.11.2 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

13.11.3 Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Jodas (India) Main Business Overview

13.11.5 Jodas (India) Latest Developments

13.12 Magnus Health (India)

13.12.1 Magnus Health (India) Company Information

13.12.2 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

13.12.3 Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Magnus Health (India) Main Business Overview

13.12.5 Magnus Health (India) Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Contrast Agents for Magnetic Resonance Imaging (MRI) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Barium-based Contrast Media

Table 4. Major Players of Iodinated Contrast Media

Table 5. Major Players of Gadolinium-based Contrast Media

Table 6. Major Players of Microbubble Contrast Media

Table 7. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2017-2022)

Table 9. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Type (2017-2022) & ($ million)

Table 10. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2017-2022)

Table 11. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2017-2022)

Table 14. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Application (2017-2022)

Table 15. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application (2017-2022)

Table 16. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Company (2020-2022)

Table 19. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Company (2020-2022)

Table 21. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Contrast Agents for Magnetic Resonance Imaging (MRI) Producing Area Distribution and Sales Area

Table 23. Players Contrast Agents for Magnetic Resonance Imaging (MRI) Products Offered

Table 24. Contrast Agents for Magnetic Resonance Imaging (MRI) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share Geographic Region (2017-2022)

Table 29. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country/Region (2017-2022)

Table 33. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2017-2022)

Table 37. Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2017-2022)

Table 39. Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2017-2022)

Table 41. Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2017-2022)

Table 43. APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2017-2022)

Table 45. APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Region (2017-2022)

Table 47. APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2017-2022)

Table 49. APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2017-2022)

Table 51. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2017-2022)

Table 53. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2017-2022)

Table 55. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2017-2022)

Table 57. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Contrast Agents for Magnetic Resonance Imaging (MRI)

Table 68. Key Market Challenges & Risks of Contrast Agents for Magnetic Resonance Imaging (MRI)

Table 69. Key Industry Trends of Contrast Agents for Magnetic Resonance Imaging (MRI)

Table 70. Contrast Agents for Magnetic Resonance Imaging (MRI) Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Contrast Agents for Magnetic Resonance Imaging (MRI) Distributors List

Table 73. Contrast Agents for Magnetic Resonance Imaging (MRI) Customer List

Table 74. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Forecast by Region

Table 76. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share Forecast by Application (2023-2028)

Table 94. GE Healthcare (US) Basic Information, Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Base, Sales Area and Its Competitors

Table 95. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

Table 96. GE Healthcare (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. GE Healthcare (US) Main Business

Table 98. GE Healthcare (US) Latest Developments

Table 99. Bracco Imaging (Italy) Basic Information, Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Base, Sales Area and Its Competitors

Table 100. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

Table 101. Bracco Imaging (Italy) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. Bracco Imaging (Italy) Main Business

Table 103. Bracco Imaging (Italy) Latest Developments

Table 104. Bayer HealthCare (Germany) Basic Information, Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Base, Sales Area and Its Competitors

Table 105. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

Table 106. Bayer HealthCare (Germany) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. Bayer HealthCare (Germany) Main Business

Table 108. Bayer HealthCare (Germany) Latest Developments

Table 109. Guerbet (France) Basic Information, Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Base, Sales Area and Its Competitors

Table 110. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

Table 111. Guerbet (France) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. Guerbet (France) Main Business

Table 113. Guerbet (France) Latest Developments

Table 114. Lantheus (US) Basic Information, Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Base, Sales Area and Its Competitors

Table 115. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

Table 116. Lantheus (US) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. Lantheus (US) Main Business

Table 118. Lantheus (US) Latest Developments

Table 119. Daiichi Sankyo (Japan) Basic Information, Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Base, Sales Area and Its Competitors

Table 120. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

Table 121. Daiichi Sankyo (Japan) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 122. Daiichi Sankyo (Japan) Main Business

Table 123. Daiichi Sankyo (Japan) Latest Developments

Table 124. Unijules Life Sciences (India) Basic Information, Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Base, Sales Area and Its Competitors

Table 125. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

Table 126. Unijules Life Sciences (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 127. Unijules Life Sciences (India) Main Business

Table 128. Unijules Life Sciences (India) Latest Developments

Table 129. J.B. Chemicals and Pharmaceuticals (India) Basic Information, Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Base, Sales Area and Its Competitors

Table 130. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

Table 131. J.B. Chemicals and Pharmaceuticals (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 132. J.B. Chemicals and Pharmaceuticals (India) Main Business

Table 133. J.B. Chemicals and Pharmaceuticals (India) Latest Developments

Table 134. Spago Nanomedicine (Sweden) Basic Information, Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Base, Sales Area and Its Competitors

Table 135. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

Table 136. Spago Nanomedicine (Sweden) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 137. Spago Nanomedicine (Sweden) Main Business

Table 138. Spago Nanomedicine (Sweden) Latest Developments

Table 139. Taejoon Pharm (South Korea) Basic Information, Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Base, Sales Area and Its Competitors

Table 140. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

Table 141. Taejoon Pharm (South Korea) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 142. Taejoon Pharm (South Korea) Main Business

Table 143. Taejoon Pharm (South Korea) Latest Developments

Table 144. Jodas (India) Basic Information, Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Base, Sales Area and Its Competitors

Table 145. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

Table 146. Jodas (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 147. Jodas (India) Main Business

Table 148. Jodas (India) Latest Developments

Table 149. Magnus Health (India) Basic Information, Contrast Agents for Magnetic Resonance Imaging (MRI) Manufacturing Base, Sales Area and Its Competitors

Table 150. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Product Offered

Table 151. Magnus Health (India) Contrast Agents for Magnetic Resonance Imaging (MRI) Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 152. Magnus Health (India) Main Business

Table 153. Magnus Health (India) Latest Developments

List of Figures

Figure 1. Picture of Contrast Agents for Magnetic Resonance Imaging (MRI)

Figure 2. Contrast Agents for Magnetic Resonance Imaging (MRI) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Contrast Agents for Magnetic Resonance Imaging (MRI) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Barium-based Contrast Media

Figure 10. Product Picture of Iodinated Contrast Media

Figure 11. Product Picture of Gadolinium-based Contrast Media

Figure 12. Product Picture of Microbubble Contrast Media

Figure 13. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Type in 2021

Figure 14. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Type (2017-2022)

Figure 15. Contrast Agents for Magnetic Resonance Imaging (MRI) Consumed in Radiology

Figure 16. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Radiology (2017-2022) & (K Pcs)

Figure 17. Contrast Agents for Magnetic Resonance Imaging (MRI) Consumed in Interventional Radiology

Figure 18. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Interventional Radiology (2017-2022) & (K Pcs)

Figure 19. Contrast Agents for Magnetic Resonance Imaging (MRI) Consumed in Interventional Cardiology

Figure 20. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Market: Interventional Cardiology (2017-2022) & (K Pcs)

Figure 21. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Application (2017-2022)

Figure 22. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Application in 2021

Figure 23. Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Company in 2021

Figure 25. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Geographic Region in 2021

Figure 27. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region (2017-2022)

Figure 28. Global Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country/Region in 2021

Figure 29. Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales 2017-2022 (K Pcs)

Figure 30. Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue 2017-2022 ($ Millions)

Figure 31. APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales 2017-2022 (K Pcs)

Figure 32. APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue 2017-2022 ($ Millions)

Figure 33. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales 2017-2022 (K Pcs)

Figure 34. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales 2017-2022 (K Pcs)

Figure 36. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue 2017-2022 ($ Millions)

Figure 37. Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country in 2021

Figure 38. Americas Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country in 2021

Figure 39. United States Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Region in 2021

Figure 44. APAC Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Regions in 2021

Figure 45. China Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country in 2021

Figure 52. Europe Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country in 2021

Figure 53. Germany Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Market Share by Country in 2021

Figure 60. Egypt Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Contrast Agents for Magnetic Resonance Imaging (MRI) Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Contrast Agents for Magnetic Resonance Imaging (MRI) in 2021

Figure 66. Manufacturing Process Analysis of Contrast Agents for Magnetic Resonance Imaging (MRI)

Figure 67. Industry Chain Structure of Contrast Agents for Magnetic Resonance Imaging (MRI)

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390